Implementation of a customised antimicrobial resistance laboratory scorecard in Cameroon, Ethiopia and Kenya

African Journal of Laboratory Medicine

 
 
Field Value
 
Title Implementation of a customised antimicrobial resistance laboratory scorecard in Cameroon, Ethiopia and Kenya
 
Creator Trollip, André Gadde, Renuka Datema, Tjeerd Gatwechi, Kamau Oskam, Linda Katz, Zachary Whitelaw, Andrew Kinyanjui, Peter Njukeng, Patrick Wendifraw, Dawit A. Mugerwa, Ibrahimm Najjuka, Grace Dayie, Nicholas Opintan, Japheth A. Albert, Heidi
 
Subject Medicine and Health; Clinical Microbiology antimicrobial resistance; laboratory; clinical; blood; urine; faeces
Description Background: In low-resource settings, antimicrobial resistance (AMR) is detected by traditional culture-based methods and ensuring the quality of such services is a challenge. The AMR Scorecard provides laboratories with a technical assessment tool for strengthening the quality of bacterial culture, identification, and antimicrobial testing procedures.Objective: To evaluate the performance of the AMR Scorecard in 11 pilot laboratory evaluations in three countries also assessed with the Stepwise Laboratory Quality Improvement Process Towards Accreditation (SLIPTA) checklist.Methods: Pilot laboratory evaluations were conducted in Cameroon, Ethiopia and Kenya between February 2019 and March 2019. Assessors with previous SLIPTA and microbiology experience were trained. Assessors performed the laboratory assessments using the SLIPTA and AMR Scorecard tools.Results: Weaknesses in technical procedures and the quality management systems were identified in all areas and all laboratories. Safety had the highest mean performance score (SLIPTA: 68%; AMR Scorecard: 73%) while management review had the lowest (SLIPTA: 32%; AMR Scorecard: 8%) across all laboratories. The AMR Scorecard scores were generally consistent with SLIPTA scores. The AMR Scorecard identified technical weaknesses in AMR testing, and SLIPTA identified weaknesses in the quality management systems in the laboratories.Conclusion: Since the AMR Scorecard identified important gaps in AMR testing not detected by SLIPTA, it is recommended that microbiology laboratories use SLIPTA and the AMR Scorecard in parallel when preparing for accreditation. Expanding the use of the AMR Scorecard is a priority to address the need for quality clinical microbiology laboratory services in support of optimal patient care and AMR surveillance. 
 
Publisher AOSIS
 
Contributor Becton Dickinson FIND Department for International Development (DFID), UK
Date 2022-06-20
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Assessment
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/ajlm.v11i1.1476
 
Source African Journal of Laboratory Medicine; Vol 11, No 1 (2022); 9 pages 2225-2010 2225-2002
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://ajlmonline.org/index.php/ajlm/article/view/1476/2258 https://ajlmonline.org/index.php/ajlm/article/view/1476/2259 https://ajlmonline.org/index.php/ajlm/article/view/1476/2260 https://ajlmonline.org/index.php/ajlm/article/view/1476/2261
 
Coverage — — —
Rights Copyright (c) 2022 André Trollip, Renuka Gadde, Tjeerd Datema, Kamau Gatwechi, Linda Oskam, Zachary Katz, Andrew Whitelaw, Peter Kinyanjui, Patrick Njukeng, Dawit A. Wendifraw, Ibrahimm Mugerwa, Grace Najjuka, Nicholas Dayie, Japheth A. Opintan, Heidi Albert https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT